(Q34571762)

3 August 2017

1 reference

title

Lymphatic dissemination of tumour cells and the formation of micrometastases (English)

1 reference

3 August 2017

Philippe O Van Trappen

series ordinal

1

1 reference

PubMed ID

11905605

3 August 2017

Michael S Pepper

series ordinal

2

1 reference

3 August 2017

1 January 2002

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

3

1 reference

3 August 2017

1

1 reference

3 August 2017

44-52

1 reference

Active interaction of human A375 melanoma cells with the lymphatics in vivo

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Prox1 function is required for the development of the murine lymphatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

LYVE-1, the lymphatic system and tumor lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Attenuated cells in breast stroma: the missing lymphatic system of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

VEGF: an update on biological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Therapeutic implications of the sentinel lymph node in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Molecular quantification and mapping of lymph-node micrometastases in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Detection and clinical importance of micrometastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

The lymph node as a bridgehead in the metastatic dissemination of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

New insights into role of microenvironment in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Genetic diagnosis of lymph-node metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Micrometastases and survival in stage II colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900621-0

7 January 2021

10.1016/S1470-2045(01)00621-0

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11905605